RepliCel Life Sciences Inc.

(RP:PUR)

By |

Profile

RepliCel Life Sciences Inc is a clinical stage bio-pharmaceutical company engaged in developing autologous cell therapies that treat functional cellular deficits. The Company\'s products include RCT-01, RCS-01 and RCH-01.

Contact Information

Website: www.replicel.com
Email: info@replicel.com
Main Phone: +1 604 248-8730
Address: 401 West Georgia Street
Address 2: Suite 2020
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6B 5A1

Issuer Information

Exchange: CDX
Employees: 16
NAICS: 541712
$ 0.50 $ 0. (0.00%)
Last Price 0.50 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.50
Last Trade Volume 0 52 Wk Hi 0.97 52 Wk Low 0.50
Market Cap 10.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,442,584.00 EPS (TTM) -0.50 PE Ratio N/A Exchange TSXV